Prelude Capital Management’s Hims & Hers Health HIMS Stock Holding History
Bought
Maintained
Sold
Other funds holding HIMS
Prelude Capital Management's HIMS Position: Q3 2026 in Review
Prelude Capital Management sold out of Hims & Hers Health (HIMS) in Q3 2026, closing a stake of 12,240 shares — an estimated $424K sold.
Prelude Capital Management first reported a position in HIMS in Q1 2021 and held it in 7 quarters. The position peaked at $437K in Q1 2025. 475 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.
- Prelude Capital Management reported no remaining Hims & Hers Health position as of Q3 2026 after selling out during the quarter.
- Prelude Capital Management sold 12,240 Hims & Hers Health shares in Q3 2026, an estimated $424K.
- Prelude Capital Management first reported a position in Hims & Hers Health in Q1 2021 and held it in 7 quarters.
- Prelude Capital Management's Hims & Hers Health position peaked at $437K in Q1 2025.
- 475 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.
Based on Prelude Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.